Journals
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 30 of 43
2020-10-21 [p.155]
— by Ms. Hajdu (Minister of Health) — Reports of the Patented Medicine Prices Review Board for the fiscal year ended March 31, 2020, pursuant to the Access to Information Act, R.S. 1985, c. A-1, sbs. 94(2) and to the Privacy Act, R.S. 1985, c. P-21, sbs. 72(2). — Sessional Paper No. 8561-432-602-01. (Pursuant to Standing Order 108(3)(h)(v), permanently referred to the Standing Committee on Access to Information, Privacy and Ethics)
2020-10-21 [p.155]
— by Ms. Hajdu (Minister of Health) — Reports of the Department of Health for the fiscal year ended March 31, 2020, pursuant to the Access to Information Act, R.S. 1985, c. A-1, sbs. 94(2) and to the Privacy Act, R.S. 1985, c. P-21, sbs. 72(2). — Sessional Paper No. 8561-432-629-01. (Pursuant to Standing Order 108(3)(h)(v), permanently referred to the Standing Committee on Access to Information, Privacy and Ethics)
2020-10-21 [p.155]
— by Ms. Hajdu (Minister of Health) — Reports of the Canadian Institutes of Health Research for the fiscal year ended March 31, 2020, pursuant to the Access to Information Act, R.S. 1985, c. A-1, sbs. 94(2) and to the Privacy Act, R.S. 1985, c. P-21, sbs. 72(2). — Sessional Paper No. 8561-432-852-01. (Pursuant to Standing Order 108(3)(h)(v), permanently referred to the Standing Committee on Access to Information, Privacy and Ethics)
2020-10-21 [p.155]
— by Ms. Hajdu (Minister of Health) — Reports of the Canadian Food Inspection Agency for the fiscal year ended March 31, 2020, pursuant to the Access to Information Act, R.S. 1985, c. A-1, sbs. 94(2) and to the Privacy Act, R.S. 1985, c. P-21, sbs. 72(2). — Sessional Paper No. 8561-432-855-01. (Pursuant to Standing Order 108(3)(h)(v), permanently referred to the Standing Committee on Access to Information, Privacy and Ethics)
2020-10-21 [p.155]
— by Ms. Hajdu (Minister of Health) — Reports of the Public Health Agency of Canada for the fiscal year ended March 31, 2020, pursuant to the Access to Information Act, R.S. 1985, c. A-1, sbs. 94(2) and to the Privacy Act, R.S. 1985, c. P-21, sbs. 72(2). — Sessional Paper No. 8561-432-936-01. (Pursuant to Standing Order 108(3)(h)(v), permanently referred to the Standing Committee on Access to Information, Privacy and Ethics)
2020-10-20 [p.143]
— by Ms. Hajdu (Minister of Health) — Interim Order Respecting the Prevention and Alleviation of Shortages of Drugs in Relation to COVID-19, pursuant to the Food and Drugs Act, R.S. 1985, c. F-27, sbs. 30.1(6) and (7). — Sessional Paper No. 8560-432-1018-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-10-19 [p.121]
— by Ms. Hajdu (Minister of Health) — Report of the Canadian Centre on Substance Abuse, together with the Auditors' Report, for the fiscal year ended March 31, 2020, pursuant to the Canadian Centre on Substance Abuse Act, R.S. 1985, c. 49 (4th Supp.), sbs. 31(2). — Sessional Paper No. 8560-432-591-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-10-19 [p.121]
— by Ms. Hajdu (Minister of Health) — Report of the Canadian Institutes of Health Research, together with the Auditors' Report, for the fiscal year ended March 31, 2020, pursuant to the Canadian Institutes of Health Research Act, S.C. 2000, c. 6, sbs. 32(2). — Sessional Paper No. 8560-432-782-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-10-19 [p.122]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2020-795, P.C. 2020-796 and P.C. 2020-797 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-432-1079-03. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-10-06 [p.89]
— by Ms. Hajdu (Minister of Health) — Copies of orders in council P.C. 2020-688 and P.C. 2020-689 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-432-1079-02. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-10-06 [p.89]
— by Ms. Hajdu (Minister of Health) — Departmental Sustainable Development Strategy of the Public Health Agency of Canada for 2020 to 2023, pursuant to the Federal Sustainable Development Act, S.C. 2008, c. 33, sbs. 11(1). — Sessional Paper No. 8560-432-1113-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Environment and Sustainable Development)
2020-10-06 [p.89]
— by Ms. Hajdu (Minister of Health) — Report on the National Strategy for Alzheimer's Disease and Other Dementias for the year 2020, pursuant to the National Strategy for Alzheimer's Disease and Other Dementias Act, S.C. 2017, c. 19, s. 5. — Sessional Paper No. 8560-432-1225-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-10-05 [p.72]
— by Ms. Hajdu (Minister of Health) — Departmental Sustainable Development Strategy of the Canadian Food Inspection Agency for 2020 to 2023, pursuant to the Federal Sustainable Development Act, S.C. 2008, c. 33, sbs. 11(1). — Sessional Paper No. 8560-432-1114-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Environment and Sustainable Development)
2020-10-05 [p.72]
— by Ms. Hajdu (Minister of Health) — Departmental Sustainable Development Strategy of the Department of Health for 2020 to 2021, pursuant to the Federal Sustainable Development Act, S.C. 2008, c. 33, sbs. 11(1). — Sessional Paper No. 8560-432-1115-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Environment and Sustainable Development)
2020-10-05 [p.72]
— by Ms. Hajdu (Minister of Health) — Order respecting other time limits and periods relating to an act or regulation for which the Minister of Health is responsible, pursuant to the Time Limits and Other Periods Act (COVID-19), S.C. 2020, c. 11, s. 11, ss. 11(1). — Sessional Paper No. 8560-432-1242-02. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-09-24 [p.15]
— by Ms. Hajdu (Minister of Health) — Orders respecting other time limits and periods relating to an act or regulation for which the Minister of Health is responsible (81200-2-543 and 81200-2-532), dated August 13, 2020, and September 16, 2020, respectively, pursuant to the Time Limits and Other Periods Act (COVID-19), S.C. 2020, c. 11, s. 11, ss. 11(1). — Sessional Paper No. 8560-432-1242-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-09-23 [p.8]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2020-565, P.C. 2020-588 and P.C. 2020-589 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-432-1079-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-08-12 [p.535]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2020-538 and P.C. 2020-549 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-431-1079-09. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-07-08 [p.494]
— by Ms. Hajdu (Minister of Health) — Report of the Patented Medicine Prices Review Board for the year ended December 31, 2018, pursuant to the Patent Act, R.S., 1985, c. P-4, sbs. 89(4) and 100(4). — Sessional Paper No. 8560-431-564-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-07-08 [p.494]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2020-468 and P.C. 2020-469 concerning minimizing the risk of exposure to COVID-19 coronavirus disease in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-431-1079-07. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-07-08 [p.494]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2020-523 and P.C. 2020-524 concerning minimizing the risk of exposure to COVID-19 coronavirus disease in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-431-1079-08. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-06-17 [p.488]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2020-370, P.C. 2020-441 and P.C. 2020-442 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-431-1079-06. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-06-03 [p.474]
— by Ms. Hajdu (Minister of Health) — Interim Order Respecting Clinical Trials for Medical Devices and Drugs relating to COVID-19, pursuant to the Food and Drugs Act, R.S. 1985, c. F-27, sbs. 30.1(6) and (7). — Sessional Paper No. 8560-431-1018-03. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-05-06 [p.419]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2020-260 and P.C. 2020-263 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-431-1079-05. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-04-20 [p.403]
Pursuant to order made earlier today, Ms. Hajdu (Minister of Health) made a statement.
2020-04-11 [p.378]
— by Ms. Hajdu (Minister of Health) — Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19, pursuant to the Food and Drugs Act, R.S. 1985, c. F-27, sbs. 30.1(6) and (7). — Sessional Paper No. 8560-431-1018-02. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-04-11 [p.378]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2020-157, P.C. 2020-161, P.C. 2020-162, P.C. 2020-175, P.C. 2020-184 and P.C. 2020-185 concerning minimizing the risk of exposure to COVID-19 coronavirus disease in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-431-1079-04. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-03-18 [p.325]
— by Ms. Hajdu (Minister of Health) — Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, pursuant to the Food and Drugs Act, R.S. 1985, c. F-27, sbs. 30.1(6) and (7). — Sessional Paper No. 8560-431-1018-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-03-12 [p.313]
— by Ms. Hajdu (Minister of Health) — Service Fees Report of the Canadian Food Inspection Agency for 2018 to 2019, pursuant to the Service Fees Act, S.C. 2017, c. 20, s. 20. — Sessional Paper No. 8560-431-1185-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2020-02-28 [p.285]
— by Ms. Hajdu (Minister of Health) — Copy of Order in Council P.C. 2020-70 dated February 17, 2020, concerning the order Minimizing the Risk of Exposure to COVID-19 Coronavirus Disease in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-431-1079-02. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
Results: 1 - 30 of 43 | Page: 1 of 2

1
2
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data